Novel Treatment, Prevention and Cure Strategies

  • Track 1-1 Preclinical drug development
  • Track 2-2 Targeting HIV persistence during ART
  • Track 3-3 Nucleic acid-based HIV therapies
  • Track 4-4 Immunotherapy

Related Conference of Immunology